171 related articles for article (PubMed ID: 32171935)
1. Methylation analysis in urine fractions for optimal CIN3 and cervical cancer detection.
van den Helder R; van Trommel NE; van Splunter AP; Lissenberg-Witte BI; Bleeker MCG; Steenbergen RDM
Papillomavirus Res; 2020 Jun; 9():100193. PubMed ID: 32171935
[TBL] [Abstract][Full Text] [Related]
2. Cervical cancer detection by DNA methylation analysis in urine.
Snoek BC; Splunter APV; Bleeker MCG; Ruiten MCV; Heideman DAM; Rurup WF; Verlaat W; Schotman H; Gent MV; Trommel NEV; Steenbergen RDM
Sci Rep; 2019 Feb; 9(1):3088. PubMed ID: 30816167
[TBL] [Abstract][Full Text] [Related]
3. HPV and DNA Methylation Testing in Urine for Cervical Intraepithelial Neoplasia and Cervical Cancer Detection.
van den Helder R; Steenbergen RDM; van Splunter AP; Mom CH; Tjiong MY; Martin I; Rosier-van Dunné FMF; van der Avoort IAM; Bleeker MCG; van Trommel NE
Clin Cancer Res; 2022 May; 28(10):2061-2068. PubMed ID: 35266975
[TBL] [Abstract][Full Text] [Related]
4. Performance of DNA methylation analysis of ASCL1, LHX8, ST6GALNAC5, GHSR, ZIC1 and SST for the triage of HPV-positive women: Results from a Dutch primary HPV-based screening cohort.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Meijer CJLM; Melchers WJG; Bekkers RL; Molijn AC; Quint WG; van Kemenade FJ; Berkhof J; Heideman DAM
Int J Cancer; 2022 Feb; 150(3):440-449. PubMed ID: 34558659
[TBL] [Abstract][Full Text] [Related]
5. Detection of hypermethylated genes as markers for cervical screening in women living with HIV.
Kremer WW; Van Zummeren M; Novianti PW; Richter KL; Verlaat W; Snijders PJ; Heideman DA; Steenbergen RD; Dreyer G; Meijer CJ
J Int AIDS Soc; 2018 Aug; 21(8):e25165. PubMed ID: 30101434
[TBL] [Abstract][Full Text] [Related]
6. Urine collection in cervical cancer screening - analytical comparison of two HPV DNA assays.
Tranberg M; Jensen JS; Bech BH; Andersen B
BMC Infect Dis; 2020 Dec; 20(1):926. PubMed ID: 33276740
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of six methylation markers derived from genome-wide screens for detection of cervical precancer and cancer.
Dick S; Verhoef L; De Strooper LM; Ciocănea-Teodorescu I; Wisman GBA; Meijer CJ; Bleeker MC; Steenbergen RD; Heideman DA
Epigenomics; 2020 Sep; 12(18):1569-1578. PubMed ID: 32938193
[No Abstract] [Full Text] [Related]
8. Genome-wide DNA methylation profiling identifies two novel genes in cervical neoplasia.
El-Zein M; Cheishvili D; Gotlieb W; Gilbert L; Hemmings R; Behr MA; Szyf M; Franco EL;
Int J Cancer; 2020 Sep; 147(5):1264-1274. PubMed ID: 31983058
[TBL] [Abstract][Full Text] [Related]
9. Performance and Diagnostic Accuracy of Human Papillomavirus Testing on Self-Collected Urine and Vaginal Samples in a Referral Population.
Cho HW; Hong JH; Min KJ; Ouh YT; Seong SJ; Moon JH; Cho SH; Lee JK
Cancer Res Treat; 2021 Jul; 53(3):829-836. PubMed ID: 33421987
[TBL] [Abstract][Full Text] [Related]
10. Complementarity between miRNA expression analysis and DNA methylation analysis in hrHPV-positive cervical scrapes for the detection of cervical disease.
Babion I; De Strooper LMA; Luttmer R; Bleeker MCG; Meijer CJLM; Heideman DAM; Wilting SM; Steenbergen RDM
Epigenetics; 2019 Jun; 14(6):558-567. PubMed ID: 30955437
[TBL] [Abstract][Full Text] [Related]
11. Quantitative analysis of methylation status of the PAX1 gene for detection of cervical cancer.
Huang TH; Lai HC; Liu HW; Lin CJ; Wang KH; Ding DC; Chu TY
Int J Gynecol Cancer; 2010 May; 20(4):513-9. PubMed ID: 20442585
[TBL] [Abstract][Full Text] [Related]
12. Role of p16(INK4a) cytology testing as an adjunct to enhance the diagnostic specificity and accuracy in human papillomavirus-positive women within an organized cervical cancer screening program.
Gustinucci D; Passamonti B; Cesarini E; Butera D; Palmieri EA; Bulletti S; Carlani A; Staiano M; D'Amico MR; D'Angelo V; Di Dato E; Martinelli N; Malaspina M; Spita N; Tintori B; Fulciniti F
Acta Cytol; 2012; 56(5):506-14. PubMed ID: 23075891
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of DNA methylation biomarkers ASCL1 and LHX8 on HPV-positive self-collected samples from primary HPV-based screening.
Verhoef L; Bleeker MCG; Polman N; Steenbergen RDM; Ebisch RMF; Melchers WJG; Bekkers RLM; Molijn AC; Quint WG; van Kemenade F; Meijer CJLM; Berkhof J; Heideman DAM
Br J Cancer; 2023 Jul; 129(1):104-111. PubMed ID: 37100874
[TBL] [Abstract][Full Text] [Related]
14. A four-gene methylation marker panel as triage test in high-risk human papillomavirus positive patients.
Eijsink JJ; Lendvai Á; Deregowski V; Klip HG; Verpooten G; Dehaspe L; de Bock GH; Hollema H; van Criekinge W; Schuuring E; van der Zee AG; Wisman GB
Int J Cancer; 2012 Apr; 130(8):1861-9. PubMed ID: 21796628
[TBL] [Abstract][Full Text] [Related]
15. Clinical and analytical evaluation of the RealTime High Risk HPV assay in Colli-Pee collected first-void urine using the VALHUDES protocol.
Van Keer S; Peeters E; Vanden Broeck D; De Sutter P; Donders G; Doyen J; Tjalma WAA; Weyers S; Vorsters A; Arbyn M
Gynecol Oncol; 2021 Sep; 162(3):575-583. PubMed ID: 34172287
[TBL] [Abstract][Full Text] [Related]
16. Effect of Screening With Primary Cervical HPV Testing vs Cytology Testing on High-grade Cervical Intraepithelial Neoplasia at 48 Months: The HPV FOCAL Randomized Clinical Trial.
Ogilvie GS; van Niekerk D; Krajden M; Smith LW; Cook D; Gondara L; Ceballos K; Quinlan D; Lee M; Martin RE; Gentile L; Peacock S; Stuart GCE; Franco EL; Coldman AJ
JAMA; 2018 Jul; 320(1):43-52. PubMed ID: 29971397
[TBL] [Abstract][Full Text] [Related]
17. DNA methylation markers as a triage test for identification of cervical lesions in a high risk human papillomavirus positive screening cohort.
van Leeuwen RW; Oštrbenk A; Poljak M; van der Zee AGJ; Schuuring E; Wisman GBA
Int J Cancer; 2019 Feb; 144(4):746-754. PubMed ID: 30259973
[TBL] [Abstract][Full Text] [Related]
18. First-void urine: A potential biomarker source for triage of high-risk human papillomavirus infected women.
Van Keer S; Pattyn J; Tjalma WAA; Van Ostade X; Ieven M; Van Damme P; Vorsters A
Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():1-11. PubMed ID: 28689156
[TBL] [Abstract][Full Text] [Related]
19. Triage of hrHPV-positive women: comparison of two commercial methylation-specific PCR assays.
Dippmann C; Schmitz M; Wunsch K; Schütze S; Beer K; Greinke C; Ikenberg H; Hoyer H; Runnebaum IB; Hansel A; Dürst M
Clin Epigenetics; 2020 Nov; 12(1):171. PubMed ID: 33176878
[TBL] [Abstract][Full Text] [Related]
20. FAM19A4/miR124-2 methylation analysis as a triage test for HPV-positive women: cross-sectional and longitudinal data from a Dutch screening cohort.
Vink FJ; Lissenberg-Witte BI; Meijer CJLM; Berkhof J; van Kemenade FJ; Siebers AG; Steenbergen RDM; Bleeker MCG; Heideman DAM
Clin Microbiol Infect; 2021 Jan; 27(1):125.e1-125.e6. PubMed ID: 32222459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
